2025 France Cell-Based Assays Market Revenue Opportunities Report
Description
The 2025 France Cell-Based Assays Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Cell-based Assays Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the cell-based assays market in France are Thermo Fisher Scientific, Merck KGaA, Lonza Group, and Corning Inc. Thermo Fisher Scientific leads globally, offering extensive primary cell culture solutions including media, cells, and reagents with robust French distribution networks. Merck KGaA, through its MilliporeSigma division, is a major supplier of cell culture media and reagents, maintaining significant operations in France. Lonza Group, headquartered in Switzerland, delivers specialized primary cell products and custom cell culture services to French pharmaceutical and biotech firms. Corning Inc. provides essential cell culture vessels and equipment widely used by French research institutions.
These companies are key contributors to France’s growing cell-based assays market, which generated USD 882.7 million in 2024 and is projected to grow to USD 1,508.9 million by 2030 at a CAGR of 9.3%. Their products support the assay kits segment, the largest revenue generator in this market. The demand is fueled by the pharmaceutical and biotechnology sectors concentrated mainly in regions like Île-de-France and Auvergne-Rhône-Alpes, where research institutions and biotech firms thrive. Other competitors like Becton Dickinson and Charles River Laboratories complement these leaders with their reagents, instruments, and contract research offerings.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Cell-based Assays Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the cell-based assays market in France are Thermo Fisher Scientific, Merck KGaA, Lonza Group, and Corning Inc. Thermo Fisher Scientific leads globally, offering extensive primary cell culture solutions including media, cells, and reagents with robust French distribution networks. Merck KGaA, through its MilliporeSigma division, is a major supplier of cell culture media and reagents, maintaining significant operations in France. Lonza Group, headquartered in Switzerland, delivers specialized primary cell products and custom cell culture services to French pharmaceutical and biotech firms. Corning Inc. provides essential cell culture vessels and equipment widely used by French research institutions.
These companies are key contributors to France’s growing cell-based assays market, which generated USD 882.7 million in 2024 and is projected to grow to USD 1,508.9 million by 2030 at a CAGR of 9.3%. Their products support the assay kits segment, the largest revenue generator in this market. The demand is fueled by the pharmaceutical and biotechnology sectors concentrated mainly in regions like Île-de-France and Auvergne-Rhône-Alpes, where research institutions and biotech firms thrive. Other competitors like Becton Dickinson and Charles River Laboratories complement these leaders with their reagents, instruments, and contract research offerings.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
